Cargando…
Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group
BACKGROUND: The outcomes of unplanned surgery for bone sarcomas have not been frequently discussed. However, it is important to recognize patterns, treatment, and clinical outcomes of unplanned surgeries for patients with bone sarcomas. This multicenter study aimed to characterize the clinical outco...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567545/ https://www.ncbi.nlm.nih.gov/pubmed/33116858 http://dx.doi.org/10.2147/CMAR.S270178 |
_version_ | 1783596346377240576 |
---|---|
author | Nakamura, Tomoki Sugaya, Jun Naka, Norifumi Kobayashi, Hiroshi Okuma, Tomotake Kunisada, Toshiyuki Asanuma, Kunihiro Outani, Hedetatsu Nishimura, Shunji Kawashima, Hiroyuki Akiyama, Toru Yasuda, Taketoshi Miwa, Shinji Sudo, Akihiro Ueda, Takafumi |
author_facet | Nakamura, Tomoki Sugaya, Jun Naka, Norifumi Kobayashi, Hiroshi Okuma, Tomotake Kunisada, Toshiyuki Asanuma, Kunihiro Outani, Hedetatsu Nishimura, Shunji Kawashima, Hiroyuki Akiyama, Toru Yasuda, Taketoshi Miwa, Shinji Sudo, Akihiro Ueda, Takafumi |
author_sort | Nakamura, Tomoki |
collection | PubMed |
description | BACKGROUND: The outcomes of unplanned surgery for bone sarcomas have not been frequently discussed. However, it is important to recognize patterns, treatment, and clinical outcomes of unplanned surgeries for patients with bone sarcomas. This multicenter study aimed to characterize the clinical outcomes of patients with bone sarcomas who underwent unplanned surgeries. PATIENTS AND METHODS: Data of 43 patients with bone sarcomas who underwent unplanned surgery between 2006 and 2017 were obtained from 23 hospitals in Japan. These included 18 cases of osteosarcoma, 9 of Ewing sarcoma, 8 of chondrosarcoma, and 6 of undifferentiated pleomorphic sarcoma. The study included 28 men and 15 women, with a mean age of 46 years. The mean follow-up duration was 59 months. RESULTS: The main primary tumor sites were the femur (n = 19), spine (n = 6), pelvis (n = 5), tibia (n = 3), and humerus (n = 3). The primary diagnoses were benign bone tumor (n = 24), trauma (n = 7), bone metastasis (n = 5), osteomyelitis (n = 4), degeneration (n=2), and unknown (n = 1). As unplanned surgeries, curettage, with or without bone graft, was performed in 26 patients; internal fixation was performed in 7; spinal surgery in 5; arthroplasty in 4; and arthroscopy in one. Thirty-eight patients received additional standard treatments. Thirty-four of these patients underwent surgical tumor resections, including amputation (n = 10), and the remaining 4 received radiotherapy or carbon ion radiotherapy as additional standard treatments. The 5-year disease-specific survival (DSS) rates in patients with osteosarcoma, Ewing sarcoma, and chondrosarcoma were 65.5%, 58.3%, and 72.9%, respectively. Twelve (27.9%) patients developed local recurrences (LR); among the total 43 patients studied, the 5-year DSS rates were significantly worse for those who developed LR compared to those who did not (p = 0.03). The 5-year DSS rates in patients with and without LR were 44% and 73.8%, respectively. CONCLUSION: We recommend that patients who have undergone unplanned surgery be administered standard treatment, including the option of amputation because herein, LR was shown to be a risk factor for decreased DSS. |
format | Online Article Text |
id | pubmed-7567545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-75675452020-10-27 Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group Nakamura, Tomoki Sugaya, Jun Naka, Norifumi Kobayashi, Hiroshi Okuma, Tomotake Kunisada, Toshiyuki Asanuma, Kunihiro Outani, Hedetatsu Nishimura, Shunji Kawashima, Hiroyuki Akiyama, Toru Yasuda, Taketoshi Miwa, Shinji Sudo, Akihiro Ueda, Takafumi Cancer Manag Res Original Research BACKGROUND: The outcomes of unplanned surgery for bone sarcomas have not been frequently discussed. However, it is important to recognize patterns, treatment, and clinical outcomes of unplanned surgeries for patients with bone sarcomas. This multicenter study aimed to characterize the clinical outcomes of patients with bone sarcomas who underwent unplanned surgeries. PATIENTS AND METHODS: Data of 43 patients with bone sarcomas who underwent unplanned surgery between 2006 and 2017 were obtained from 23 hospitals in Japan. These included 18 cases of osteosarcoma, 9 of Ewing sarcoma, 8 of chondrosarcoma, and 6 of undifferentiated pleomorphic sarcoma. The study included 28 men and 15 women, with a mean age of 46 years. The mean follow-up duration was 59 months. RESULTS: The main primary tumor sites were the femur (n = 19), spine (n = 6), pelvis (n = 5), tibia (n = 3), and humerus (n = 3). The primary diagnoses were benign bone tumor (n = 24), trauma (n = 7), bone metastasis (n = 5), osteomyelitis (n = 4), degeneration (n=2), and unknown (n = 1). As unplanned surgeries, curettage, with or without bone graft, was performed in 26 patients; internal fixation was performed in 7; spinal surgery in 5; arthroplasty in 4; and arthroscopy in one. Thirty-eight patients received additional standard treatments. Thirty-four of these patients underwent surgical tumor resections, including amputation (n = 10), and the remaining 4 received radiotherapy or carbon ion radiotherapy as additional standard treatments. The 5-year disease-specific survival (DSS) rates in patients with osteosarcoma, Ewing sarcoma, and chondrosarcoma were 65.5%, 58.3%, and 72.9%, respectively. Twelve (27.9%) patients developed local recurrences (LR); among the total 43 patients studied, the 5-year DSS rates were significantly worse for those who developed LR compared to those who did not (p = 0.03). The 5-year DSS rates in patients with and without LR were 44% and 73.8%, respectively. CONCLUSION: We recommend that patients who have undergone unplanned surgery be administered standard treatment, including the option of amputation because herein, LR was shown to be a risk factor for decreased DSS. Dove 2020-10-12 /pmc/articles/PMC7567545/ /pubmed/33116858 http://dx.doi.org/10.2147/CMAR.S270178 Text en © 2020 Nakamura et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Nakamura, Tomoki Sugaya, Jun Naka, Norifumi Kobayashi, Hiroshi Okuma, Tomotake Kunisada, Toshiyuki Asanuma, Kunihiro Outani, Hedetatsu Nishimura, Shunji Kawashima, Hiroyuki Akiyama, Toru Yasuda, Taketoshi Miwa, Shinji Sudo, Akihiro Ueda, Takafumi Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group |
title | Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group |
title_full | Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group |
title_fullStr | Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group |
title_full_unstemmed | Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group |
title_short | Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group |
title_sort | standard treatment remains the recommended approach for patients with bone sarcoma who underwent unplanned surgery: report from the japanese musculoskeletal oncology group |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567545/ https://www.ncbi.nlm.nih.gov/pubmed/33116858 http://dx.doi.org/10.2147/CMAR.S270178 |
work_keys_str_mv | AT nakamuratomoki standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup AT sugayajun standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup AT nakanorifumi standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup AT kobayashihiroshi standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup AT okumatomotake standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup AT kunisadatoshiyuki standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup AT asanumakunihiro standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup AT outanihedetatsu standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup AT nishimurashunji standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup AT kawashimahiroyuki standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup AT akiyamatoru standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup AT yasudataketoshi standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup AT miwashinji standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup AT sudoakihiro standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup AT uedatakafumi standardtreatmentremainstherecommendedapproachforpatientswithbonesarcomawhounderwentunplannedsurgeryreportfromthejapanesemusculoskeletaloncologygroup |